menu
    • menu
    [{"orgOrder":0,"company":"Samsung Medical Center","sponsor":"Bukwang Pharmaceutical Co., Ltd | ChunLab, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SOUTH KOREA","productType":"Plant Extract\/Herbal","year":"2018","type":"Inapplicable","leadProduct":"Tritriacontanoic Acid","moa":"Muscarinic acetylcholine receptor M5 (CHRM5)","graph1":"Endocrinology","graph2":"Phase IV","graph3":"Samsung Medical Center","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Granules","sponsorNew":"Samsung Medical Center \/ Bukwang Pharmaceutical Co., Ltd | ChunLab, Inc.","highestDevelopmentStatusID":"11","companyTruncated":"Samsung Medical Center \/ Bukwang Pharmaceutical Co., Ltd | ChunLab, Inc."},{"orgOrder":0,"company":"University of Nottingham","sponsor":"Ironwood Pharmaceuticals","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"UNITED KINGDOM","productType":"Plant Extract\/Herbal","year":"2013","type":"Inapplicable","leadProduct":"Tritriacontanoic Acid","moa":"Muscarinic acetylcholine receptor M5 (CHRM5)","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"University of Nottingham","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Nottingham \/ Ironwood Pharmaceuticals","highestDevelopmentStatusID":"1","companyTruncated":"University of Nottingham \/ Ironwood Pharmaceuticals"},{"orgOrder":0,"company":"University of Nottingham","sponsor":"Ironwood Pharmaceuticals","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"UNITED KINGDOM","productType":"Plant Extract\/Herbal","year":"2014","type":"Inapplicable","leadProduct":"Tritriacontanoic Acid","moa":"Muscarinic acetylcholine receptor M5 (CHRM5)","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"University of Nottingham","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Nottingham \/ Ironwood Pharmaceuticals","highestDevelopmentStatusID":"1","companyTruncated":"University of Nottingham \/ Ironwood Pharmaceuticals"}]

    Find Clinical Drug Pipeline Developments & Deals for Tritriacontanoic Acid

    Menu

    Tritriacontanoic Acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Samsung Medical Center

                            Country arrow
                            OTS 2025
                            Not Confirmed

                            Samsung Medical Center

                            Country arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tritriacontanoic Acid

                            Therapeutic Area : Endocrinology

                            Study Phase : Phase IV

                            Sponsor : Bukwang Pharmaceutical Co., Ltd | ChunLab, Inc.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of Dietary Fiber on Glucose Control in Subjects With Type 2 Diabetes Mellitus

                            Details : Ispaghula is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Diabetes Mellitus, Type 2.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            June 12, 2018

                            Lead Product(s) : Tritriacontanoic Acid

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Phase IV

                            Sponsor : Bukwang Pharmaceutical Co., Ltd | ChunLab, Inc.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            University of Nottingham

                            Country arrow
                            OTS 2025
                            Not Confirmed

                            University of Nottingham

                            Country arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tritriacontanoic Acid

                            Therapeutic Area : Gastroenterology

                            Study Phase : Undisclosed

                            Sponsor : Ironwood Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            MRI and Microbiota Analysis in Constipation

                            Details : Ispaghula is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Constipation.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            May 22, 2014

                            Lead Product(s) : Tritriacontanoic Acid

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Undisclosed

                            Sponsor : Ironwood Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            University of Nottingham

                            Country arrow
                            OTS 2025
                            Not Confirmed

                            University of Nottingham

                            Country arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tritriacontanoic Acid

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Ironwood Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Ispaghula and Colonic Water Content

                            Details : Ispaghula is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            March 06, 2013

                            Lead Product(s) : Tritriacontanoic Acid

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Ironwood Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth